CharlesrivP
This role involves providing strategic scientific guidance for the advancement of innovative medicines from discovery through clinical development within the Safety Assessment business units. The position requires developing and implementing nonclinical pharmacology and toxicology strategies to support regulatory interactions and global registration objectives. The individual will serve as a subject matter expert, leading multidisciplinary teams and addressing complex scientific and regulatory issues for advanced therapeutic modalities.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CharlesrivP.
32% above the average for this role
Translational Lead
Tonix Pharmaceuticals
Nonclinical Safety and Pathobiology Group Leader
Gilead Sciences
Director, Toxicology
Praxis Precision Medicines, Inc.
Principal Scientist - Toxicology
AbCellera
Pioneering Medicines: Senior Director, Head of Toxicology
Flagship Pioneering, Inc.
Director, Toxicology Translational Science
Tarsus Pharmaceuticals